Scott M. Coiante - Aug 25, 2021 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
SVP, Chief Financial Officer
Signature
/s/ Scott M. Coiante
Stock symbol
APRE
Transactions as of
Aug 25, 2021
Transactions value $
-$29,985
Form type
4
Date filed
8/27/2021, 05:01 PM
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Tax liability -$30K -7.53K -7.61% $3.98 91.5K Aug 25, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 21,166 restricted stock units.